THE NOVEL GALECTIN-3 INHIBITOR GB1211 REDUCES INFLAMMATION & FIBROSIS IN A RABBIT HIGH FAT DIET MODEL OF NASH & FIBROSIS

被引:0
|
作者
Slack, Robert [1 ]
Comeglio, Paolo [2 ]
Filippi, Sandra [2 ]
Guarnieri, Giulia [3 ]
Cellai, Ilaria [3 ]
Adorini, Luciano [4 ]
Morelli, Annamaria [3 ]
Vignozzi, Linda [5 ]
Maggi, Mario [3 ]
机构
[1] Galecto Biotech AB, Boston, MA USA
[2] Univ Florence, Dept Expt & Clin Biochem Sci Mario Serio, Florence, Italy
[3] Univ Florence, Florence, Italy
[4] Ist Nazl Biostrutture & Biosistemi, Rome, Italy
[5] Univ Florence, Sexual Med & Androl, Florence, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
5042
引用
收藏
页码:E153 / E153
页数:1
相关论文
共 50 条
  • [21] Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets
    Pejnovic, Nada N.
    Pantic, Jelena M.
    Jovanovic, Ivan P.
    Radosavljevic, Gordana D.
    Milovanovic, Marija Z.
    Nikolic, Ivana G.
    Zdravkovic, Nemanja S.
    Djukic, Aleksandar L.
    Arsenijevic, Nebojsa N.
    Lukic, Miodrag L.
    DIABETES, 2013, 62 (06) : 1932 - 1944
  • [22] Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
    Jeftic, Ilija
    Jovicic, Nemanja
    Pantic, Jelena
    Arsenijevic, Nebojsa
    Lukic, Miodrag L.
    Pejnovic, Nada
    MOLECULAR MEDICINE, 2015, 21 : 453 - 465
  • [23] Excessive sucrose exacerbates high fat diet-induced hepatic inflammation and fibrosis promoting osteoarthritis in mice model
    Min, Yunhui
    Ahn, Dohyun
    Kim, Mangeun
    Heo, Yunji
    Jee, Youngheun
    Son, Young-Ok
    Kang, Inhae
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2023, 112
  • [24] Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis
    Ilija Jeftic
    Nemanja Jovicic
    Jelena Pantic
    Nebojsa Arsenijevic
    Miodrag L. Lukic
    Nada Pejnovic
    Molecular Medicine, 2015, 21 : 453 - 465
  • [25] n-3 PUFA AND UDCA CO-TREATMENT REDUCES INFLAMMATION AND FIBROSIS BUT NOT STEATOSIS AND BALLOONING CHANGE IN MURINE NASH MODEL
    Kim, J. K.
    Lee, S. Y.
    Chang, H. Y.
    Chung, H. J.
    Lee, J. I.
    Lee, K. S.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S514 - S515
  • [26] Early phase 1 clinical trial results of GR-MD-02, a galectin-3 inhibitor, in patients having non-alcoholic steatohepatitis (NASH) with advanced fibrosis
    Harrison, Stephen A.
    Chalasani, Naga P.
    Lawitz, Eric
    Marri, Smitha
    Noureddin, Mazen
    Sanyal, Arun J.
    Schiano, Thomas D.
    Siddiqui, Mohammad S.
    Neuschwander-Tetri, Brent A.
    Traber, Peter G.
    HEPATOLOGY, 2014, 60 : 225A - 226A
  • [27] PBI-4050 reduces liver damage and fibrosis in a high-fat diet mouse model of obesity and metabolic syndrome
    Grouix, B.
    Sarra-Bournet, F.
    Tremblay, M.
    Felton, A.
    Laurin, P.
    Gagnon, L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S165 - S165
  • [28] Intermittent Fasting Reduces Neuroinflammation and Cognitive Impairment in High-Fat Diet-Fed Mice by Downregulating Lipocalin-2 and Galectin-3
    Lee, Jaewoong
    An, Hyeong Seok
    Shin, Hyun Joo
    Jang, Hye Min
    Im, Chae Oh
    Jeong, Yeonjun
    Eum, Kibaek
    Yoon, Sejeong
    Lee, So Jeong
    Jeong, Eun Ae
    Kim, Kyung Eun
    Roh, Gu Seob
    NUTRIENTS, 2024, 16 (01)
  • [29] Td139, A Novel Inhaled Galectin-3 Inhibitor For The Treatment Of Idiopathic Pulmonary Fibrosis (ipf). Results From The First In (ipf) Patients Study
    Hirani, N.
    Mackinnon, A.
    Nicol, L.
    Walker, J.
    Ford, P.
    Schambye, H.
    Pederson, A.
    Nilsson, U.
    Leffler, H.
    Thomas, T.
    Francombe, D.
    Simpson, J.
    Gibbons, M.
    Maher, T. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [30] Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model
    Sabir, Usman
    Irfan, Hafiz Muhammad
    Alamgeer
    Ullah, Aman
    Althobaiti, Yusuf S.
    Alshehri, Fahad S.
    Niazi, Zahid Rasul
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150